drugs
-
More investment needed in anti-obesity drugs
Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, a report by GlobalData has found.
drugs | 01 May 2012
-
Emphasis on reconstituting drugs at the point-of-care driven by growth in lyophilized drugs
The push to intuitive technology is seen as reducing medication errors according to Greystone Research Associates.
drugs | 14 March 2012
-
PharmaTag monitors critical drugs during transportation
European based company Dyzle (www.Dyzle.com) is launching its new leading edge solution for the pharmaceutical industry – the PharmaTag. The approach is simple: a thin measuring device, the size of a credit card, travels with the product during its…
drugs | 07 September 2011
-
The other drug problem
There is a new front in the war on drugs, and it's not the kind of drugs one might think.
drugs | 01 September 2011
-
FUJIFILM, Dr Reddy's establish exclusive joint venture on generic drugs in Japan
FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr Reddy's Laboratories Ltd Vice-Chairman and CEO, G V Prasad signed a memorandum of understanding to enter into an exclusive partnership in the generic drugs business for the Japanese mark…
drugs | 29 July 2011
-
Sanofi, DNDi to generate new drugs for neglected tropical diseases
Sanofi and Drugs for Neglected Diseases initiative (DNDi) announced a three-year research collaboration agreement for the research of new treatments for nine neglected tropical diseases (NTDs). These diseases are listed by the World Health Organizati…
drugs | 30 May 2011
-
Proteomics in action: Opening doorways to new drugs
Proteomics is opening the door to personalised drug discovery through the study of disease specific biomarkers.
drugs | 01 May 2011
-
Specialty injectable drugs to top US$90 billion by 2014
Driven by greater patient acceptance and evolving formulation and administration options, the global value of specialty injectable drugs in key market segments will grow to more than US$90 billion over the next four years, according to the estimates …
drugs | 28 January 2011
-
Majority of sales derives from mature drugs
The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, while the proportion of total sales from newer drugs has dropped, according to data released from the 2010 Pharmaceutical R&D Factbook complied by CMR I…
drugs | 01 August 2010
-
New multiple sclerosis drugs set to capture market share
The Russian approval of Merck Serono’s Movectro (oral cladribine) is a landmark in the treatment for relapse-remitting multiple sclerosis (RRMS) patients, as it becomes the world’s first oral disease-modifying MS therapy to be granted marketing a…
drugs | 19 July 2010
